PRP Therapy for Joint Pain in Mehsana, Non-Surgical Treatment at Axcura Ortho

PRP therapy has demonstrated meaningful pain relief and functional improvement in patients with knee osteoarthritis Grades 1 to 3 and in patients with patellar and other tendon conditions around the knee. Results are best in patients with early to moderate degeneration rather than end-stage arthritis where joint space is fully collapsed.

Most patients receive a course of 2 to 3 injections spaced 2 to 4 weeks apart. A single injection may be sufficient for tendon conditions. The number of injections recommended is determined after assessment at Axcura Ortho.

The injection itself involves brief discomfort similar to any joint injection. Most patients experience mild soreness at the injection site for 24 to 48 hours after the procedure. This is a normal response as the growth factors begin working.

In appropriately selected patients, PRP therapy provides meaningful pain relief for 6 to 18 months. Individual results vary depending on the degree of joint degeneration and patient activity level.

PRP does not cure or reverse osteoarthritis but it can meaningfully reduce pain and slow the progression of joint inflammation, which for some patients delays the need for replacement surgery by months to years. It is one of several non-surgical options discussed at Axcura Ortho before replacement is considered.

Yes. Patients from Visnagar, Unjha, Patan, Sidhpur, Vadnagar and across North Gujarat are seen at Axcura Ortho for PRP therapy and other non-surgical joint treatments.

PRP uses the patient's own concentrated growth factors to stimulate healing in damaged tissue — particularly cartilage, tendons and joints with degeneration. Prolotherapy uses a dextrose solution to strengthen lax or structurally compromised ligaments and tendons through a controlled inflammatory stimulus. The two treatments serve overlapping but distinct clinical purposes and are sometimes used in combination.

The injection itself produces brief, moderate discomfort at the site. Post-injection soreness lasting 24 to 72 hours is expected and indicates the treatment is initiating the intended inflammatory-repair response. Most patients find the discomfort manageable and reduces with successive sessions.

Most patients receive 3 to 6 sessions spaced 3 to 6 weeks apart. Some chronic or complex conditions may require additional sessions. Improvement is typically noticed from the second or third session onwards, with maximum benefit assessed at the completion of the full course.

Yes. In selected cases, prolotherapy and PRP are used together — prolotherapy to address ligament laxity and structural instability, PRP to support tissue healing in the affected joint or tendon. The combined approach is discussed where both mechanisms are relevant to the patient's condition.

Not all injections require guidance. For some easily palpable, superficial structures, landmark-guided injection is clinically adequate. Guidance is recommended wherever the target is deep, difficult to palpate reliably, or where accurate placement is critical to the outcome — such as the hip joint, rotator cuff structures, or small tendon sheaths.

Ultrasound guidance does not add pain to the procedure. It adds a transducer on the skin surface and allows the clinician to place the needle more accurately, often reducing the number of needle passes needed. Most patients report no difference in discomfort compared to palpation-guided injections.

Most USG-guided injection procedures take 15 to 30 minutes, including preparation, scanning, injection and a brief post-procedure observation period. The ultrasound component adds minimal time while significantly improving placement accuracy.

Yes. PRP and prolotherapy injections are frequently delivered under ultrasound guidance at Axcura Ortho where the target structure benefits from image-confirmed placement. This is particularly relevant for deep structures, small tendon sheaths and areas where palpation accuracy is limited.